178 related articles for article (PubMed ID: 10718182)
1. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children's Oncology Group Studies AREN03B2 and AREN0532.
Evageliou N; Renfro LA; Geller J; Perlman E; Kalapurakal J; Paulino A; Dix D; Eklund MJ; Murphy AJ; Romao RLP; Ehrlich PF; Varela CR; Vallance K; Fernandez CV; Dome JS; Mullen EA
Cancer; 2024 Mar; 130(5):792-802. PubMed ID: 37902955
[TBL] [Abstract][Full Text] [Related]
3. Deletion of WT1 and WIT1 genes and loss of heterozygosity on chromosome 11p in Wilms tumors in Japan.
Kaneko Y; Takeda O; Homma C; Maseki N; Miyoshi H; Tsunematsu Y; Williams BG; Saunders GF; Sakurai M
Jpn J Cancer Res; 1993 Jun; 84(6):616-24. PubMed ID: 8393432
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and Clinical Outcomes of Children With Wilms' Tumour: A 15-year Experience in a Single Centre in Nigeria.
Nasir AA; Abdur-Raheem NT; Abdur-Rahman LO; Ibiyeye TT; Sayomi TO; Adedoyin OT; Adeniran JO
J Pediatr Surg; 2024 May; 59(5):1009-1014. PubMed ID: 38184433
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity for chromosomes 16q in Wilms tumors predicts outcomes: A meta-analysis.
Song YH; Li WL; Yang Z; Gao Y; Feng ZP
World J Gastrointest Oncol; 2024 May; 16(5):2159-2167. PubMed ID: 38764827
[TBL] [Abstract][Full Text] [Related]
6. Effect of miR-590-3p/DKK1 Axis on the Progression of Wilms' Tumour.
Wang H; Zhang Y
Arch Esp Urol; 2024 Mar; 77(2):135-141. PubMed ID: 38583005
[TBL] [Abstract][Full Text] [Related]
7. The UMBRELLA SIOP-RTSG 2016 Wilms tumour pathology and molecular biology protocol.
Vujanić GM; Gessler M; Ooms AHAG; Collini P; Coulomb-l'Hermine A; D'Hooghe E; de Krijger RR; Perotti D; Pritchard-Jones K; Vokuhl C; van den Heuvel-Eibrink MM; Graf N;
Nat Rev Urol; 2018 Nov; 15(11):693-701. PubMed ID: 30310143
[TBL] [Abstract][Full Text] [Related]
8. Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor.
Green DM
J Clin Oncol; 2020 Mar; 38(7):772-773. PubMed ID: 31951492
[No Abstract] [Full Text] [Related]
9. Multidimensional Transcriptomics Unveils RNF34 as a Prognostic Biomarker and Potential Indicator of Chemotherapy Sensitivity in Wilms' Tumour.
Zheng J; Liu F; Tuo J; Chen S; Su J; Ou X; Ding M; Chen H; Shi B; Li Y; Chen X; Wang C; Su C
Mol Biotechnol; 2024 May; 66(5):1132-1143. PubMed ID: 38195816
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic results in stage I Wilms' tumors in children - 15 years of surgical experience.
Szymik-Kantorowicz S; Urbanowicz W; Surmiak M; Sulisławski J
Cent European J Urol; 2012; 65(3):151-5. PubMed ID: 24578953
[TBL] [Abstract][Full Text] [Related]
11. Different incidence of loss of heterozygosity on chromosome 16q between intraductal papilloma and intracystic papillary carcinoma of the breast.
Tsuda H; Uei Y; Fukutomi T; Hirohashi S
Jpn J Cancer Res; 1994 Oct; 85(10):992-6. PubMed ID: 7961109
[TBL] [Abstract][Full Text] [Related]
12. Transcriptomic Analyses of MYCN-Regulated Genes in Anaplastic Wilms' Tumour Cell Lines Reveals Oncogenic Pathways and Potential Therapeutic Vulnerabilities.
Szemes M; Melegh Z; Bellamy J; Park JH; Chen B; Greenhough A; Catchpoole D; Malik K
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33562123
[TBL] [Abstract][Full Text] [Related]
13. Case Report: Autosomal dominant polycystic kidney disease and Wilms' tumor in infancy and childhood.
Zina D; Rosita K; Kristina Z; Giedre R; Jurate M
Front Pediatr; 2024; 12():1322142. PubMed ID: 38577638
[TBL] [Abstract][Full Text] [Related]
14. A Gradual Transition Toward Anaplasia in Wilms Tumor Through Tolerance to Genetic Damage.
Uno K; Rastegar B; Jansson C; Durand G; Valind A; Chattopadhyay S; Bertolotti A; Ciceri S; Spreafico F; Collini P; Perotti D; Mengelbier LH; Gisselsson D
Mod Pathol; 2024 Jan; 37(1):100382. PubMed ID: 37951357
[TBL] [Abstract][Full Text] [Related]
15. Wilms tumour resulting from paternal transmission of a TRIM28 pathogenic variant-A first report.
Whitworth J; Armstrong R; Maher ER
Eur J Hum Genet; 2024 Mar; 32(3):361-364. PubMed ID: 38282073
[TBL] [Abstract][Full Text] [Related]
16. Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration.
Dome JS; Graf N; Geller JI; Fernandez CV; Mullen EA; Spreafico F; Van den Heuvel-Eibrink M; Pritchard-Jones K
J Clin Oncol; 2015 Sep; 33(27):2999-3007. PubMed ID: 26304882
[TBL] [Abstract][Full Text] [Related]
17. Adult Wilms' Tumour: Case Report and Review of Literature.
Modi S; Tiang KW; Inglis P; Collins S
J Kidney Cancer VHL; 2016; 3(2):1-7. PubMed ID: 28326278
[TBL] [Abstract][Full Text] [Related]
18. Prenatal exposure to air toxics and risk of Wilms' tumor in 0- to 5-year-old children.
Shrestha A; Ritz B; Wilhelm M; Qiu J; Cockburn M; Heck JE
J Occup Environ Med; 2014 Jun; 56(6):573-8. PubMed ID: 24854250
[TBL] [Abstract][Full Text] [Related]
19. Stage at diagnosis and survival by stage for the leading childhood cancers in three populations of sub-Saharan Africa.
Parkin DM; Youlden DR; Chitsike I; Chokunonga E; Couitchéré L; Gnahatin F; Nambooze S; Wabinga H; Aitken JF
Int J Cancer; 2021 Jun; 148(11):2685-2691. PubMed ID: 33433927
[TBL] [Abstract][Full Text] [Related]
20. Anaplasia in Wilms tumor: A critical review.
Vujanić GM; Mifsud W
Pediatr Blood Cancer; 2024 Apr; ():e31000. PubMed ID: 38605554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
